Preconceptional genetic carrier testing and the commercial offer directly-to-consumers

被引:59
作者
Borry, Pascal [1 ,2 ,3 ,4 ]
Henneman, Lidewij [2 ,3 ]
Lakeman, Phillis [2 ,3 ]
ten Kate, Leo P. [2 ,3 ]
Cornel, Martina C. [2 ,3 ]
Howard, Heidi C. [1 ]
机构
[1] Katholieke Univ Leuven, Ctr Biomed Eth & Law, B-3000 Louvain, Belgium
[2] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands
[3] EMGO Inst Hlth & Care Res, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands
关键词
preconception care; carrier testing; direct-to-consumer; CYSTIC-FIBROSIS; SCREENING-PROGRAMS; GAUCHER-DISEASE; POPULATION; ATTITUDES; IMPACT; CARE; THALASSEMIA; BENEFIT;
D O I
10.1093/humrep/der042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Recently, a number of commercial companies are offering preconceptional carrier tests directly-to-consumers. This offer raises a number of concerns and issues above and beyond those encountered with preconceptional tests offered within the traditional health care setting. In order to bring some of these issues to light and to initiate dialogue on this topic, this article discusses the following issues: the current offer of preconceptional carrier tests (until the end of 2010) through online commercial companies; the implications for the informed consent procedure and the need for good information; the need for medical supervision and follow-up; and the appropriate use of existing resources. The article concludes with some reflections about the potential sustainability of the offer of preconceptional carrier tests directly-to-consumers.
引用
收藏
页码:972 / 977
页数:6
相关论文
共 46 条
[1]  
Advisory Committee on Genetic Testing, 1998, 2 HLTH DEP UK
[2]  
[Anonymous], 1968, PUBLIC HLTH PAP, DOI DOI 10.1001/ARCHINTE.1969.00300130131020
[3]  
[Anonymous], 2010, A common framework of principles for direct-to-consumer genetic testing services
[4]  
Axworthy D, 1996, LANCET, V347, P1443
[5]   UPTAKE OF CYSTIC-FIBROSIS TESTING IN PRIMARY-CARE - SUPPLY PUSH OR DEMAND PULL [J].
BEKKER, H ;
MODELL, M ;
DENNISS, G ;
SILVER, A ;
MATHEW, C ;
BOBROW, M ;
MARTEAU, T .
BRITISH MEDICAL JOURNAL, 1993, 306 (6892) :1584-1586
[6]   THE IMPACT OF POPULATION-BASED SCREENING FOR CARRIERS OF CYSTIC-FIBROSIS [J].
BEKKER, H ;
DENNISS, G ;
MODELL, M ;
BOBROW, M ;
MARTEAU, T .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (05) :364-368
[7]   Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening [J].
Bombard, Yvonne ;
Miller, Fiona A. ;
Hayeems, Robin Z. ;
Avard, Denise ;
Knoppers, Bartha M. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (07) :751-760
[8]   Carrier screening for type 1 Gaucher disease: difficult questions [J].
Borry, Pascal ;
Clarke, Angus ;
Dierickx, Kris .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (02) :139-140
[9]   Where are you going, where have you been: A recent history of the direct-to-consumer genetic testing market [J].
Borry P. ;
Cornel M.C. ;
Howard H.C. .
Journal of Community Genetics, 2010, 1 (3) :101-106
[10]   Benchmarks for Cystic Fibrosis carrier screening: A European consensus document [J].
Castellani, Carlo ;
Macek, Milan, Jr. ;
Cassiman, Jean-Jacques ;
Duff, Alistair ;
Massie, John ;
ten Kate, Leo P. ;
Barton, David ;
Cutting, Garry ;
Dallapiccola, Bruno ;
Dequeker, Elisabeth ;
Girodon, Emmanuelle ;
Grody, Wayne ;
Highsmith, Edward W. ;
Kaariainen, Helenal ;
Kruip, Stephan ;
Morris, Michael ;
Pignatti, Pier Franco ;
Pypops, Ulrike ;
Schwarz, Martin ;
Soller, Maria ;
Stuhrman, Manfred ;
Cuppens, Harry .
JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (03) :165-178